DiLunBio: Your Trusted Partner in Automated Peptide Synthesis

Our Roots

Beijing Dilun Biotechnology Co., Ltd. shares the same roots with Peptide Scientific Inc. (PSI), USA, serving as its extension and development arm in China. Since its establishment in 2012, Dilun Bio has inherited PSI’s technological DNA and management system, while also advancing innovation through independent research — specializing in the development and manufacturing of solid-phase peptide synthesis equipment.

Independent Innovation

DiLun Bio has independently developed key instruments including peptide synthesizers and peptide cleavage systems, building a comprehensive instrument matrix that supports peptide synthesis from research to pilot scale-up and industrial production. The company is dedicated to providing efficient, intelligent, and environmentally friendly peptide synthesis solutions to the global scientific and pharmaceutical community.

Design Philosophy

Dilun Bio’s design philosophy is rooted in energy conservation, environmental sustainability, and intelligent manufacturing. Advanced technologies include:

· Solvent recycling & waste reduction
· Microwave-assisted, energy-efficient heating
· Digital management for enhanced efficiency
· Asynchronous multi-channel operation & remote smart control

These innovations maximize energy efficiency, reduce carbon emissions, and enable the creation of integrated peptide production systems that are efficient, low-consumption, and green.

Global Adoption

To date, Dilun Bio’s instruments have been adopted by 50+ academic institutions and 30+ pharmaceutical enterprises across China, including Peking University, Tsinghua University, Hengrui Pharma, and Yangtze River Pharmaceutical Group. Products are also exported to 10+ countries such as the United States, Germany, Australia, and Greece, with a steadily expanding international customer base.

Looking Ahead

Dilun Bio will continue to uphold its philosophy of heritage and innovation, intelligent manufacturing, green efficiency, and shared progress, contributing to the global life sciences and pharmaceutical industries through sustainable, high-performance solutions. Looking forward, Dilun Bio will uphold its philosophy of "heritage and innovation, intelligent manufacturing, green efficiency, and shared progress," and continue exploring new frontiers in peptide synthesis technologies, contributing to the global life sciences and pharmaceutical industries through sustainable and high-performance solutions.

What We Stand For

We are engineers of the molecular world and enablers behind the progress of life sciences.

In an era driven by data and defined by discovery, we are committed to building precise, efficient, and reliable peptide synthesis platforms. Our technology supports researchers, pharmaceutical developers, and biotech innovators worldwide—empowering them to unlock the secrets at the heart of life.

Every peptide chain is a sentence in the language of life.

Life extends beyond humans. As signaling molecules, regulators, and therapeutic agents, peptides play vital roles in humans, animals, plants, and microorganisms alike.
Our instruments don’t just synthesize molecules—they help scientists narrate the story of life, restore health, explore evolution, and connect intelligence across species.

We bridge the microscopic and the meaningful—making life more measurable, more understandable, and more respected.

Whether it’s enabling breakthroughs in oncology, improving pet health, enhancing plant immunity, or developing environmentally friendly microbial solutions—peptide science is at the frontier of modern biology.
We stand as a technical partner to science, offering powerful synthesis solutions for a healthier, smarter, and more ecologically conscious world.

Peptides are our way of expressing love and protection for life. Through science and technology, we do more than synthesize molecules—we connect lives, inspire hope, and uphold biodiversity.

Looking ahead, Dilun Bio will remain committed to its core values: heritage and innovation, intelligent manufacturing, green efficiency, and collaborative growth. We aim to become a global leader and innovation driver in solid-phase peptide synthesis equipment. Guided by the principle of sustainable and efficient synthesis, we provide high-quality, scenario-adaptive solutions for the life sciences and pharmaceutical industries. We will continue to push the boundaries of peptide technology and contribute to a greener, more sustainable future for the global life sciences ecosystem.

Partner Brands

Advanced ChemTech (ACT) has officially authorized Dilun Bio as its maintenance service provider for peptide synthesizers in mainland China. Dilun Bio is responsible for sales support, installation, technical training, and after-sales services, ensuring that Chinese customers receive expert-level support and reliable equipment services.

Analytical Technologies Limited is a high-tech multinational company with presence in 96+ countries, specializing in analytical, chromatography, spectroscopy, biotechnology, biomedical, clinical diagnostics, and material science instrumentation. Our product range covers turnkey lab setups, HPLC/GC/IC systems, LCMS/GCMS/ICPMS series, MALDI-TOF, ICP-OES, FTIR, SEM/TEM/XRD/XRF, MRI/CT, hematology & biochemistry analyzers, PCR/RT-PCR, ELISA systems, particle analyzers, DSC/TGA, and more.Analytical Technologies Limited (India) is our authorized agent, responsible for sales and promotion of our products in India and international markets.

Our Team

Peptide Scientific Inc. (PSI) is a U.S.-based high-tech company specializing in the R&D and manufacturing of peptide synthesis equipment. PSI provides comprehensive and intelligent peptide synthesis solutions for global research institutions and pharmaceutical companies, covering laboratory R&D, pilot testing, and industrial production. Its core technologies include advanced 180° flip mixing and modular design, setting benchmarks for efficiency and product quality.

PSI’s cutting-edge technologies are seamlessly integrated with Dilun Bio's localized innovation and services. With a shared origin and tightly aligned standards, Dilun Bio brings PSI’s advanced technology to China, providing local clients with superior peptide synthesizer solutions and achieving both technological continuity and innovative progress.

At Dilun Bio, we bring together a professional team specializing in peptide synthesis equipment R&D, engineering, and customer support. With deep industry experience and hands-on expertise, we provide comprehensive services including equipment selection, customized solution design, on-site installation, technical training, and responsive after-sales support.

Our Clients

Dilun Bio’s products are widely used in top research institutions such as Peking University, Tsinghua University, Shanghai Jiao Tong University, Sichuan University, Lanzhou University, and South China University of Technology. They are also trusted by leading pharmaceutical companies like Hengrui Pharma, Yangtze River Pharmaceutical Group, and Hansoh Pharma.
In addition, Dilun Bio's equipment has been exported to countries including the United States, Germany, Greece, Iran, Australia, New Zealand, Japan, and Russia—gaining a strong international reputation and broadening its global market reach.

010203

2003:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2004:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2005:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2006:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2007:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

0102030405

2008:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2009:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2010:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2011:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2012:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

0102030405

Our History

Major historical events

1995-2025

1995:

Dr. John Ye introduced the 180° reactor inversion mixing mode, eliminating resin damage from mechanical stirring and achieving >99.5% coupling efficiency.

2000:

PSI developed an FDA 21 CFR Part 11–compliant electronic records and signature system to ensure secure and compliant data management.

2001:

PSI invented solvent recirculation technology reducing solvent use and waste by 40%, and built the first fully automated 316L stainless steel peptide synthesizer.

2002:

Peptide Scientific Inc. was founded, launching the PSI500 synthesizer that integrated inversion mixing, solvent recycling, compliance software, and stainless steel design for scalable long-peptide production.

2012:

PSI founded Beijing Dilun Biotechnology to carry forward its advanced technologies and act as its main platform for future growth.

2015:

PSI launched a peptide cleavage instrument tailored to the Chinese market, completing its full R&D-to-production equipment portfolio.

2025:

PSI introduced the 386 Pro twelve-channel asynchronous microscale peptide synthesizer, enabling independent multi-channel synthesis and high-throughput complex peptide production.

01020304050607

2000:

PSI developed an FDA 21 CFR Part 11–compliant electronic records and signature system to ensure secure and compliant data management.

2004:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2005:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2006:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2007:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

0102030405

2001:

PSI invented solvent recirculation technology reducing solvent use and waste by 40%, and built the first fully automated 316L stainless steel peptide synthesizer.

2009:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2010:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2011:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2012:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

0102030405

2002:

2009:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2010:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2011:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2012:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

0102030405

2012:

PSI founded Beijing Dilun Biotechnology to carry forward its advanced technologies and act as its main platform for future growth.

2009:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2010:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2011:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2012:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

0102030405

2015:

PSI launched a peptide cleavage instrument tailored to the Chinese market, completing its full R&D-to-production equipment portfolio.

2009:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2010:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2011:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

2012:

Establishment of Hybio Pharmaceutical, marking the beginning of our journey.

0102030405

2025:

PSI introduced the 386 Pro twelve-channel asynchronous microscale peptide synthesizer, enabling independent multi-channel synthesis and high-throughput complex peptide production.